2,197 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
PFE Pfizer, Inc. $43.01 $252.13B Downtrend
Article Searches
A grandpa's hope for hemophilia cure leads him to gene therapy clinical trial https://www.cnbc.com/2018/11/16/biomarins-hemophilia-gene-therapy-offers-patients-a-hope-for-a-cure.html Nov 16, 2018 - BioMarin's clinical trial of a gene therapy for hemophilia is providing hope to patients with the disease. It is an experimental treatment that uses a virus to deliver a healthy copy of a gene to make up for one that causes excessive bleeding.
uniQure Up on Positive Data From Mid-Stage Hemophilia Study http://www.zacks.com/stock/news/337966/uniqure-up-on-positive-data-from-mid-stage-hemophilia-study?cid=CS-ZC-FT-337966 Nov 16, 2018 - uniQure's (QURE) gene therapy candidate, AMT-061, demonstrates significant improvement in hemophilia B patients in a mid-stage study. Investors' sentiment improves.
Road To Financial Independence: Growing Dividends, Endless Opportunities But Limited Capital https://seekingalpha.com/article/4222058-road-financial-independence-growing-dividends-endless-opportunities-limited-capital?source=feed_all_articles Nov 14, 2018 - Dividend income hit $205 in dividends, up 39% Y/Y and up 4% sequentially.Endless opportunities in October led to some active buying and selling as some of the most solid dividend-paying stocks went on
Shire's Filing Accepted by FDA for Gattex's Label Expansion http://www.zacks.com/stock/news/337411/shires-filing-accepted-by-fda-for-gattexs-label-expansion?cid=CS-ZC-FT-337411 Nov 14, 2018 - The FDA accepts Shire's (SHPG) sNDA and is expected to take action in March 2019.
Richard Bernstein Advisors LLC Buys SPDR Select Sector Fund - Health Care, PowerShares DB ... http://www.gurufocus.com/news/770018/richard-bernstein-advisors-llc-buys-spdr-select-sector-fund--health-care-powershares-db-optimum-yield-diversified-commoditi-unitedhealth-group-inc-sells-ishares-core-msci-emerging-markets-vaneck-vectors-junior-gold-miners-general-electric-co Nov 13, 2018 - Richard Bernstein Advisors LLC Buys SPDR Select Sector Fund - Health Care, PowerShares DB Optimum Yield Diversified Commoditi, UnitedHealth Group Inc, Sells iShares Core MSCI Emerging Markets, VanEck Vectors Junior Gold Miners, General Electric Co, Stocks: UNH,PFE,ABBV,MRK,CCK,INTC,XLV,PDBC,AMGN,ABT,MDT,BM, release date:Nov 13, 2018
DekaBank Deutsche Girozentrale Buys Pfizer Inc, Emerson Electric Co, WEC Energy Group Inc, ... http://www.gurufocus.com/news/768518/dekabank-deutsche-girozentrale-buys-pfizer-inc-emerson-electric-co-wec-energy-group-inc-sells-chevron-corp-schlumberger-lam-research-corp Nov 09, 2018 - DekaBank Deutsche Girozentrale Buys Pfizer Inc, Emerson Electric Co, WEC Energy Group Inc, Sells Chevron Corp, Schlumberger, Lam Research Corp, Stocks: PFE,EMR,WEC,CLX,NVDA,PVH,CCEP,LIN,TLRY,SF,BRX,HPP,, release date:Nov 09, 2018
Cancer Research Highlight: Pfizer Looks To Re-Enter The ALK Race https://seekingalpha.com/article/4220306-cancer-research-highlight-pfizer-looks-re-enter-alk-race?source=feed_sector_healthcare Nov 09, 2018 - Recent FDA news puts Pfizer all along the treatment continuum for ALK-positive lung cancer.Along with their other TKIs, lorlatinib has shown huge promise, particularly for patients with brain metastas
Pharma Stock Roundup: LLY, AZN Report Q3 Earnings, PFE Gets FDA Nod for Cancer Drug http://www.zacks.com/stock/news/336619/pharma-stock-roundup-lly-azn-report-q3-earnings-pfe-gets-fda-nod-for-cancer-drug?cid=CS-ZC-FT-336619 Nov 09, 2018 - Lilly (LLY) and AstraZeneca (AZN) report third-quarter results. Pfizer (PFE) gains FDA approval for a new cancer medicine.
Nektar (NKTR) Q3 Earnings & Sales Beat Estimates, Shares Up http://www.zacks.com/stock/news/336416/nektar-nktr-q3-earnings-sales-beat-estimates-shares-up?cid=CS-ZC-FT-336416 Nov 08, 2018 - Nektar's (NKTR) earnings and sales beat estimates in the third quarter. The company enters oncology clinical collaboration with Pfizer to evaluate NKTR-214 combination therapy.
Cramer's advice on investing during Washington gridlock: Buy fast growers https://www.cnbc.com/2018/11/07/cramers-advice-on-investing-during-dc-gridlock-buy-fast-growers.html Nov 07, 2018 - Jim Cramer recommends stocks like Amazon and Apple in the wake of the 2018 midterm elections, in which Democrats regained control in the House of Representatives.

Pages: 123456...220

Page 1>

Related Companies

Name Exchange Price Mkt Cap
NVS Novartis AG NYSE $85.13 $197.65B
MRK Merck & Company, Inc. NYSE $70.42 $187.28B
ABBV AbbVie Inc. NYSE $95.37 $144.42B
JNJ Johnson & Johnson NYSE $139.96 $375.48B
ABT Abbott Laboratories NYSE $67.67 $118.71B
Sector: Health Care > Industry: Major Pharmaceuticals
DeepLinks for Pfizer